Blood Utilization and Transfusion Reactions in Pediatric Patients Transfused with Conventional or Pathogen Reduced Platelets
| Autor: | Edward L. Snyder, Wade L. Schulz, Nathaniel Price, Rebecca Ross, Eric A. Gehrie, Amit Gokhale, Burak Bahar, Bryan R. Spencer, Jacob McPadden |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Neonatal intensive care unit Adolescent Population Red Blood Cell Transfusion Platelet Transfusion 03 medical and health sciences 0302 clinical medicine Age groups 030225 pediatrics Internal medicine medicine Humans Platelet 030212 general & internal medicine Child education Infection Control education.field_of_study Red Cell business.industry Infant Newborn Infant Transfusion Reaction Bacterial Infections Tertiary care hospital Platelet transfusion Virus Diseases Child Preschool Pediatrics Perinatology and Child Health business Procedures and Techniques Utilization |
| Zdroj: | The Journal of Pediatrics. 209:220-225 |
| ISSN: | 0022-3476 |
| Popis: | To assess the safety and efficacy of a Food and Drug Administration-approved pathogen-reduced platelet (PLT) product in children, as ongoing questions regarding their use in this population remain.We report findings from a quality assurance review of PLT utilization, associated red blood cell transfusion trends, and short-term safety of conventional vs pathogen-reduced PLTs over a 21-month period while transitioning from conventional to pathogen-reduced PLTs at a large, tertiary care hospital. We assessed utilization in neonatal intensive care unit (NICU) patients, infants 0-1 year not in the NICU, and children age 1-18 years (PED).In the 48 hours after an index conventional or pathogen-reduced platelet transfusion, respectively, NICU patients received 1.0 ± 1.4 (n = 91 transfusions) compared with 1.2 ± 1.3 (n = 145) additional platelet doses (P = .29); infants 0-1 year not in the NICU received 2.8 ± 3.0 (n = 125) vs 2.6 ± 2.6 (n = 254) additional platelet doses (P = .57); and PEDs received 0.9 ± 1.6 (n = 644) vs 1.4 ± 2.2 (n = 673) additional doses (P .001). Time to subsequent transfusion and red cell utilization were similar in every group (P .05). The number and type of transfusion reactions did not significantly vary based on PLT type and no rashes were reported in NICU patients receiving phototherapy and pathogen-reduced PLTs.Conventional and pathogen-reduced PLTs had similar utilization patterns in our pediatric populations. A small, but statistically significant, increase in transfusions was noted following pathogen-reduced PLT transfusion in PED patients, but not in other groups. Red cell utilization and transfusion reactions were similar for both products in all age groups. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect